Multiplatform Molecular Profiling: A Precision Medicine Victory Built on Cytotoxic Chemotherapy
- PMID: 30896527
- PMCID: PMC6430143
- DOI: 10.1097/PPO.0000000000000359
Multiplatform Molecular Profiling: A Precision Medicine Victory Built on Cytotoxic Chemotherapy
Comment on
-
Treatment According to a Comprehensive Molecular Profiling Can Lead to a Better Outcome in Heavily Pretreated Patients With Metastatic Cancer: Data of a Pooled Analysis.Cancer J. 2019 Mar/Apr;25(2):73-79. doi: 10.1097/PPO.0000000000000358. Cancer J. 2019. PMID: 30896526
References
-
- Impact of Precision Medicine in Diverse Cancers: A Meta-Analysis of Phase II Clinical Trials Schwaederle Maria, Zhao Melissa, Lee J. Jack, Eggermont Alexander M., Schilsky Richard L., Mendelsohn John, Lazar Vladimir, and Kurzrock Razelle Journal of Clinical Oncology 2015. 33:32, 3817–3825 - PMC - PubMed
-
- Montemurro F, Valabrega G, Aglietta M. Trastuzumab treatment in breast cancer. N Engl J Med. 2006;354:2186. - PubMed
-
- Druker BJ, Guilhot F, O’Brien SG, et al. Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia. N Engl J Med. 2006;355:2408–2417. - PubMed
-
- Dalle S, Poulalhon N, Thomas L. Vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med. 2011;365:1448–1450. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources